Electrostimulation Study for Ocular Graft vs. Host Disease

Conditions

• Chronic Ocular Graft-versus-host Disease

Eligibility Criteria

Sex

ALL

Age

18 Years - 75 Years

Healthy Volunteers

Not accepted

Interventions

• Electrodes with Currents — DEVICE
  Electrodes will be placed on the cheeks and forehead, and treated with an amplitude of 300 µA for 30 mins
• Electrodes without Currents — DEVICE
  Electrodes will be placed on the cheeks and forehead, and treated with an no amplitude for 30 mins

Study Details

This trial is testing to see if electrostimulation treatment (ET) will be effective in treating those with ocular Graft vs. Host Disease.

Key Dates

Start date

Nov 30, 2025

Status verified

Dec 2025

Primary completion

Nov 30, 2028

Completion

Nov 30, 2029

Study Design

Enrollment

15 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Arms

• Experimental: Electrostimulation
  The experimental group will entail the subject wearing the electrodes on the cheeks and forehead, for 30 minutes WITH amplitude.
• Sham Comparator: Sham
  The placebo group will entail the subject wearing the electrodes on the cheeks and forehead, for 30 minutes WITHOUT amplitude.

Primary Outcome Measure

Efficacy of Electrostimulation (ES) Treatment. [ Time Frame: 8 Weeks ]

Central Contacts

• Michael Cheung, MSc, CCRP
  6175736060
  [email protected]

Locations (1)

Find similar trials in Boston, MA